| Names | |
|---|---|
| Preferred IUPAC name
3-[5-(Aminomethyl)-4-(carboxymethyl)-1H-pyrrol-3-yl]propanoic acid | |
| Identifiers | |
3D model (JSmol) |
|
| ChemSpider | |
| DrugBank | |
| ECHA InfoCard | 100.006.970 |
| EC Number |
|
| MeSH | Porphobilinogen |
PubChem CID |
|
| UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C10H14N2O4 | |
| Molar mass | 226.229 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
Porphobilinogen (PBG) is an organic compound that occurs in living organisms as an intermediate in the biosynthesis of porphyrins, which include critical substances like hemoglobin and chlorophyll.
Porphobilinogen can be described as a pyrrole with substituents at positions 2, 3 and 4. These substituents are respectively, an aminomethyl group −CH2−NH2, a carboxymethyl group −CH2−COOH, and a carboxyethyl group −CH2−CH2−COOH.
In an early step of the porphyrin biosynthesis pathway, porphobilinogen is generated from aminolevulinic acid (ALA) by the enzyme ALA dehydratase.
Next in the pathway towards porphyrins, four molecules of porphobilinogen are combined into hydroxymethyl bilane by the enzyme porphobilinogen deaminase:
Acute intermittent porphyria causes an increase in urinary porphobilinogen.